Veru, Inc. CEO Mitch Steiner Discusses Recent Enobosarm Data and Preserving Muscle While on GLP-1 Obesity Drugs.

Send us Fan MailCEO Mitch Steiner joins us on this week’s collaboration with WTR Biotech Spotlight to talk about the next generation of drugs focusing on lean mass (muscle) preservation for obesity patients on the popular GLP-1 therapies. He reviews the recent enobosarm Phase 2b data and highlights the importance of functional clinical benefit in addition to maintaining lean mass. Listen to learn more about Veru and its obesity drug enobosarm.

Episode metadata supplied by the publisher feed · Published Feb 26, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Veru, Inc. CEO Mitch Steiner Discusses Recent Enobosarm Data and Preserving Muscle While on GLP-1 Obesity Drugs.

0:00 34:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Thinking Cap Solutions Podcast Mickey Maher & Corey Kay 🎙 Thinking Cap Solutions Podcast – Unlock the power of content, audience engagement, and leadership.With 30+ years in media, content strategy, and senior leadership, Mickey & Corey share real-world lessons, insights, and strategies to help brands, businesses, and leaders grow.🚀 From podcasting and content creation to audience engagement and leadership coaching, we break down what works, what doesn’t, and how to cut through the noise.🎧 Listen, learn, and lead with impact.

Frequently Asked Questions

How long is this episode of WTR Small-Cap Spotlight?

This episode is 34 minutes long.

When was this WTR Small-Cap Spotlight episode published?

This episode was published on February 26, 2025.

Can I download this WTR Small-Cap Spotlight episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!